Brain Tissue Prostaglandins and Ischemic Edema: Cause or Coincidence?

  • K. K. Bhakoo
  • H. A. Crockard
  • P. T. Lascelles
  • S. F. Avery


Previous studies have suggested that “ischemic brain edema” has both cytotoxic and vasogenic features13. The mechanism for the formation of this edema is complicated, but it is established that extracellular ionic migration2 and protein extravasation5 play a role particularly if cerebral blood flow (CBF) is less than 7 ml/ 100 g/min. At this point it is known that disruption of cellular membranes occurs with maximal edema formation7. Following such damage to cell membranes, Wolfe and Coceani22 have emphasized that release of prostaglandins (PG) occurs. Edema formation at low levels of CBF is reduced by pretreatment with indomethacin and more effectively by dexamethasone12. The question arises, therefore, as to whether or not edema formation during severe ischemia is PG-mediated.


Cerebral Blood Flow Brain Edema Vasogenic Edema Brain Water Content Carotid Occlusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abdel-Halim MS, Sjoquist B, Anggard E: Inhibition of prostaglandin synthesis in rat brain. Acta Pharmacol et Toxicol 43: 266–272 (1978).CrossRefGoogle Scholar
  2. 2.
    Astrup J, Symon L, Brandston NM, Lassen NA: Cortical evoked potential extracellular K+ and H+ at critical levels of brain ischaemia. Stroke 8: 51–57 (1977).CrossRefGoogle Scholar
  3. 3.
    Avery SF, Crockard HA, Ross-Russell RW: Evolution of reperfusion oedema in severe bilateral ischaemia in the gerbil (submitted).Google Scholar
  4. 4.
    Bhakoo KK, Crockard HA, Lascelles PT, Avery SF: Prostaglandin synthesis and oedema formation during reperfusion following experimental brain ischaemia in the gerbil (submitted).Google Scholar
  5. 5.
    Brightman MW: The intracerebral movement of protein injected into blood and cerebrospinal fluid of mice. In: Brain Barrier Systems. Lajtha A, Ford DH (Eds.) Progress in Brain Research, Elsevier, Amsterdam 29: 19–37, (1968).CrossRefGoogle Scholar
  6. 6.
    Chan PH, Fishman RA: Brain edema: Induction in cortical slices by polyunsaturated fatty acids. Science 201: 358–360 (1978).CrossRefGoogle Scholar
  7. 7.
    Crockard A, Iannotti F, Hunstock AT, Smith RD, Harris RJ, Symon L: Cerebral blood flow and edema following carotid occlusion in the gerbil. Stroke 11: 494–498 (1980).CrossRefGoogle Scholar
  8. 8.
    Crockard HA, Bhakoo KK, Lascelles PT: Regional prostaglandin levels in cerebral ischaemia. J Neurochem 38: 1311–1314 (1982).CrossRefGoogle Scholar
  9. 9.
    Demopolous HB, Milvy P, Kakari S, Ransohoff J: Molecular aspects of membrane structure in cerebral edema. In: Steroids and Brain Edema. Reulen HJ, Schurmann K (Eds.) Springer Berlin-Heidelberg-New York 29–39 (1972).CrossRefGoogle Scholar
  10. 10.
    Flower RJ, Cheung HS, Cushman DW: Quantitative determination of prostaglandins and malondialdehyde formed by the arachidonate oxygenase system of bovine seminal vesicles. Prostaglandins 4: 325–341 (1973).Google Scholar
  11. 11.
    Flower RJ, Blackwell GJ: Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature 278: 456–459 (1979).CrossRefGoogle Scholar
  12. 12.
    Iannotti F, Crockard A, Ladds G, Symon L: Are prostaglandins involved in experimental ischaemic edema in gerbils? Stroke 12: 301–306 (1981).CrossRefGoogle Scholar
  13. 13.
    Klatzo I: Neuropathological aspects of brain edema: Presidential address. J Neuropath exp Neurol 26: 1–14 (1967).CrossRefGoogle Scholar
  14. 14.
    Klatzo I: Pathophysiological aspects of brain edema. In: Steroids and Brain Edema. Reulen HJ, Schurmann K (Eds.) Springer-Verlag, Berlin-Heidelberg-New York 1–8 (1972).CrossRefGoogle Scholar
  15. 15.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin-phenol reagent. J Biol Chem 193: 265–275 (1951).Google Scholar
  16. 16.
    McGiff JC: Prostaglandins, prostacyclin, and thromboxanes. Ann Rev Pharmacol Toxicol 21: 479–509 (1981).CrossRefGoogle Scholar
  17. 17.
    Nelson SR, Mantz ML, Maxwell JA: Use of specific gravity in the measurement of cerebral edema. J Appl Physiol 30: 267–271 (1971).Google Scholar
  18. 18.
    Pickard JD: Role of prostaglandins and arachidonic acid derivatives in the coupling of cerebral blood flow to cerebral metabolism. J Cereb Blood Flow Metabol 1: 361–384 (1981).CrossRefGoogle Scholar
  19. 19.
    Porcellati G, De Medio GE, Floridi A, Goracci G, Horrocks LA, Lazarewicz JW, Palmerini GA, Strosznajder J, Trovarelli G: Phospholipid and its metabolism in ischaemia. In: Proceedings of the European Society for Neurochemistry. Neuhoff U (Ed.) Verlag-Chemie 1: (1978).Google Scholar
  20. 20.
    Smith FL, Carpenter MP: Free radicals produced during prostaglandin synthesis. Fed Proc 40: 1713 (1981).Google Scholar
  21. 21.
    Tarn S, Hong SL, Levine L: Relationship among the steroids of anti-inflammatory properties and inhibition of prostaglandin production and arachidonic acid release by transformed mouse fibroblasts. J Pharmacol exp Ther 203: 162–168 (1977).Google Scholar
  22. 22.
    Wolfe LS, Coceani F: The role of prostaglandins in the central nervous system. Ann Rev Physiol 41: 669–684 (1979).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • K. K. Bhakoo
    • 1
  • H. A. Crockard
    • 1
  • P. T. Lascelles
    • 1
  • S. F. Avery
    • 1
  1. 1.The National Hospital for Nervous DiseasesLondonEngland

Personalised recommendations